Weill Cornell Medicine on the Upper East Side seeks a leader to direct a focused team advancing next-generation tumor-infiltrating lymphocyte therapies. You will reprogram and optimize TILs through media, metabolic interventions, and gene engineering to enhance potency and clinical efficacy.
This role bridges discovery and translational product development, translating mechanistic insights into scalable processes and IND-ready candidates, while mentoring a high-performance team and collaborating
#J-18808-LjbffrLead TIL Reprogramming & Translational Immunotherapy in new york at Unknown Company
This position is listed as full time and onsite.